Parkinson’s Disease Skin Biopsy Study
Study to Improve Diagnosis & Assessment of Parkinson’s Disease, Progressive Supranuclear Palsy & Other Parkinsonism
HEALTHY PARTICIPANTS: Yes
The purpose of this study is to determine whether identification of misfolded proteins in the skin will help to determine what sort of parkinsonism someone has. We seek to demonstrate whether someone has a synucleinopathy such as Parkinson's disease (PD), multiple system atrophy (MSA), or dementia with Lewy bodies(DLB), as opposed to a tauopathy such as progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD) or no parkinsonism at all (control).
Who Can Participate
Participants between 21 and 89 years of age diagnosed with Parkinson’s Disease, dementia with Lewy bodies, multiple system atrophy, progressive supranuclear palsy or corticobasal degeneration may be eligible for this study. Participants without any neurological disease may also be eligible.